Design of peptide–dendrimer conjugates with tumor homing and antitumor effects

Peptide-based tumor inhibitor encoding mitochondrial p14ARFis highly efficacious to diverse tumors

(2016) Ken Saito et al.   CANCER SCIENCE

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Peptide therapeutics: current status and future directions

(2015) Keld Fosgerau et al.   DRUG DISCOVERY TODAY

Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications

(2014) R. M. Kannan et al.   JOURNAL OF INTERNAL MEDICINE

Antitumor Impact of p14ARF on Gefitinib-Resistant Non-Small Cell Lung Cancers

(2013) K. Saito et al.   MOLECULAR CANCER THERAPEUTICS

Enzyme-responsive nanoparticles for drug release and diagnostics

(2012) Roberto de la Rica et al.   ADVANCED DRUG DELIVERY REVIEWS

Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems

(2012) Eisaku Kondo et al.   Nature Communications

Multifunctional dendritic polymers in nanomedicine: opportunities and challenges

(2011) Jayant Khandare et al.   CHEMICAL SOCIETY REVIEWS

Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine

(2010) Didier Astruc et al.   CHEMICAL REVIEWS

Nanomedicine-Challenge and Perspectives

(2009) Kristina Riehemann et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines

(2008) Eisaku Kondo et al.   MOLECULAR CANCER THERAPEUTICS

Cysteine cathepsin proteases as pharmacological targets in cancer

(2007) Carmela Palermo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES